Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Finasteride and dutasteride both improve hair growth effectively, but dutasteride has stronger anti-androgen effects and finasteride may cause more sexual side effects.

High doses of testosterone disrupt hormone levels and receptor expression in the uterus, affecting fertility.

Dutasteride helps hair growth in those unresponsive to finasteride, but may cause more sexual dysfunction.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

The levonorgestrel implant increases free testosterone and lowers SHBG more than DMPA-IM and the copper IUD.

Testosterone patches can modestly improve sexual function in postmenopausal women not on estrogen therapy.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Combining β-sitosterol nanoparticles with laser therapy may effectively stimulate hair growth in androgenetic alopecia.

Progesterone byproduct 5αP stimulates mammary tumor growth, but finasteride can suppress it.

Urtica dioica extract may help treat androgenic skin diseases by reducing a specific gene's activity.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

Liposomes can make the antiandrogen RU 58841 more effective for skin application by reducing absorption, increasing skin retention, and targeting sebaceous structures.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Human prostate cells produce more WISP1/CCN4 when there's not enough oxygen.

Women with androgenetic alopecia have normal levels of most blood steroids and binding proteins, but higher dehydroepiandrosterone. Some also have low "sex hormone-binding globulin" and "corticosteroide-binding globulin" capacity, and high "free androgen index" and "free cortisol index". Diane treatment can normalize these levels and improve hair conditions.

Topical 17 alpha-propylmesterolone increases hair cell growth in androgenetic alopecia.

A testosterone-induced hair loss model in mice was successfully created for future research and treatment testing.

Flutamide emulgel with 1% Transcutol P absorbs better through the skin than other mixtures.

DHEA did not improve sexual function, well-being, or menopausal symptoms in postmenopausal women with low libido but caused side effects like acne and increased facial hair.

A new microneedle treatment can help regrow hair by improving lymphatic function and metabolism.

The over-the-counter supplement DHEA could make COVID-19 worse, especially in diabetics and people with G6PD deficiency.

Tiny lipid particles loaded with a hormone gather in hair follicles, which may help treat hair loss.

Testosterone undecanoate can reduce the negative effects of Finasteride on male reproductive health.

The herbal mix (Biochanin A, Acetyl tetrapeptide-3, and Ginseng Extracts) and the 3% Minoxidil solution are equally effective in treating hair loss, but the herbal mix has fewer side effects.

A brominated phenoxy compound effectively inhibits a human enzyme and shows potential for clinical use.

Testosterone undecanoate caused hair loss; finasteride improved it but caused stomach issues for one patient.